// App-Quantinova.ai

4280 : Paralleled workflow for expansion of limited patient material using CRC for in vitro/PDX/biological/genetic studies of a low-grade mucoepidermoid carcinoma

Researchers

Presenter

  • Ahmad M. Alamri

Principal Investigators

  • Xuefeng Liu

  • Weisheng Wang

  • Xiaogang Zhong

  • Bhaskar Kallakury

  • Bruce Davidson

  • Priscilla A. Furth

Medical Centers

  • Georgetown University, King Khalid University, Washington, DC

  • Georgetown University, Washington, DC

  • Georgetown University, Washington, DC

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Mucoepidermoid carcinoma

  • Solid malignancies

Biomarkers

  • Amphiregulin

  • Aurora kinase A

  • Breast cancer type 2 susceptibility protein

  • C-C Motif Chemokine Ligand 28

  • Phosphorylated endothelial growth factor receptor

  • Phosphorylated-AKT

  • Serine/threonine-protein kinase mTOR

  • Translocator protein

  • Tumor protein p53

Drug/Treatment

  • amphiregulin

  • Methadone hydrochloride

  • Y-27632

  • TP53

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved